
Samuel A. Acquah
Examiner (ID: 3913)
| Most Active Art Unit | 1711 |
| Art Unit(s) | 1503, 1711, 1774, 2899, 1207, 1754 |
| Total Applications | 2690 |
| Issued Applications | 2329 |
| Pending Applications | 91 |
| Abandoned Applications | 269 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19098149
[patent_doc_number] => 20240117377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN GABAERGIC NEURONS AND ASTROCYTES
[patent_app_type] => utility
[patent_app_number] => 18/263930
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263930
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263930 | ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN GABAERGIC NEURONS AND ASTROCYTES | Feb 1, 2022 | Pending |
Array
(
[id] => 17593522
[patent_doc_number] => 20220143095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => NOVEL ANUCLEATED CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/581329
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581329 | NOVEL ANUCLEATED CELLS AND USES THEREOF | Jan 20, 2022 | Abandoned |
Array
(
[id] => 17828420
[patent_doc_number] => 20220265724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => CELL THERAPEUTIC AGENT FOR ANTI-INFLAMMATORY OR DAMAGED TISSUE REGENERATION COMPRISING PRUSSIAN BLUE NANOPARTICLES, AND METHOD FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/571116
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/571116 | CELL THERAPEUTIC AGENT FOR ANTI-INFLAMMATORY OR DAMAGED TISSUE REGENERATION COMPRISING PRUSSIAN BLUE NANOPARTICLES, AND METHOD FOR PREPARING THE SAME | Jan 6, 2022 | Pending |
Array
(
[id] => 17532373
[patent_doc_number] => 20220110982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/556330
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556330 | MAPC TREATMENT OF BRAIN INJURIES AND DISEASES | Dec 19, 2021 | Abandoned |
Array
(
[id] => 17546685
[patent_doc_number] => 20220118026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/556380
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556380 | MAPC TREATMENT OF BRAIN INJURIES AND DISEASES | Dec 19, 2021 | Abandoned |
Array
(
[id] => 19049298
[patent_doc_number] => 20240091267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => PRE-TREATMENT OF MSC WITH PPARB/DELTA AGONIST FOR TREATMENT OF ISCHEMIA-REPERFUSION INJURY
[patent_app_type] => utility
[patent_app_number] => 18/267957
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267957
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267957 | PRE-TREATMENT OF MSC WITH PPARB/DELTA AGONIST FOR TREATMENT OF ISCHEMIA-REPERFUSION INJURY | Dec 16, 2021 | Pending |
Array
(
[id] => 17519308
[patent_doc_number] => 20220105156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => METHODS OF TREATMENT FOR KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/644244
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/644244 | METHODS OF TREATMENT FOR KIDNEY DISEASE | Dec 13, 2021 | Pending |
Array
(
[id] => 18879419
[patent_doc_number] => 20240002788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => Regenerative Tissue Extract from Non-Human Mammalian Placenta
[patent_app_type] => utility
[patent_app_number] => 18/039372
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039372
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039372 | Regenerative Tissue Extract from Non-Human Mammalian Placenta | Dec 2, 2021 | Pending |
Array
(
[id] => 19049303
[patent_doc_number] => 20240091272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => ENGINEERED MULTICELLULAR ORGANISMS
[patent_app_type] => utility
[patent_app_number] => 18/254929
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254929
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254929 | ENGINEERED MULTICELLULAR ORGANISMS | Nov 29, 2021 | Pending |
Array
(
[id] => 18893764
[patent_doc_number] => 20240009249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => ADIPOGENIC CELL COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/038630
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038630
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038630 | ADIPOGENIC CELL COMPOSITIONS AND METHODS | Nov 23, 2021 | Pending |
Array
(
[id] => 17458742
[patent_doc_number] => 20220072046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS
[patent_app_type] => utility
[patent_app_number] => 17/534513
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/534513 | MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS | Nov 23, 2021 | Pending |
Array
(
[id] => 19081861
[patent_doc_number] => 20240108662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => ENGINEERED CELLS FUNCTIONALIZED WITH IMMUNE CHECKPOINT MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/039387
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039387
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039387 | ENGINEERED CELLS FUNCTIONALIZED WITH IMMUNE CHECKPOINT MOLECULES AND USES THEREOF | Nov 22, 2021 | Pending |
Array
(
[id] => 17444088
[patent_doc_number] => 20220064593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS RELATING TO PLURIPOTENT CELLS
[patent_app_type] => utility
[patent_app_number] => 17/526885
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17526885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/526885 | METHODS RELATING TO PLURIPOTENT CELLS | Nov 14, 2021 | Pending |
Array
(
[id] => 17867372
[patent_doc_number] => 20220290108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 17/510717
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17510717
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/510717 | OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM | Oct 25, 2021 | Abandoned |
Array
(
[id] => 18511616
[patent_doc_number] => 20230227786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => PREPARATION METHOD AND RECOVERY METHOD OF PARIDUVAL MESENCHYMAL STEM CELLS (PMSCs)
[patent_app_type] => utility
[patent_app_number] => 18/009473
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009473 | PREPARATION METHOD AND RECOVERY METHOD OF PARIDUVAL MESENCHYMAL STEM CELLS (PMSCs) | Oct 21, 2021 | Pending |
Array
(
[id] => 17383905
[patent_doc_number] => 20220031757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHOD FOR REPAIRING DAMAGED TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/503756
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503756 | METHOD FOR REPAIRING DAMAGED TISSUE | Oct 17, 2021 | Abandoned |
Array
(
[id] => 17519397
[patent_doc_number] => 20220105245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => BONE-LIKE PROSTHETIC IMPLANTS
[patent_app_type] => utility
[patent_app_number] => 17/500341
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500341 | BONE-LIKE PROSTHETIC IMPLANTS | Oct 12, 2021 | Abandoned |
Array
(
[id] => 17370279
[patent_doc_number] => 20220025331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => METHODS AND SYSTEMS FOR IMPROVING CELLS FOR USE IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/496391
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/496391 | METHODS AND SYSTEMS FOR IMPROVING CELLS FOR USE IN THERAPY | Oct 6, 2021 | Pending |
Array
(
[id] => 19186253
[patent_doc_number] => 20240165166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE
[patent_app_type] => utility
[patent_app_number] => 18/043064
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043064
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043064 | PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE | Sep 29, 2021 | Pending |
Array
(
[id] => 18771123
[patent_doc_number] => 20230365933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING STEM CELL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/246710
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246710 | COMPOSITIONS AND METHODS FOR INCREASING STEM CELL FUNCTION | Sep 27, 2021 | Pending |